| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |